Comparison of Synthetic Media Designed for Expansion of Adipose-Derived Mesenchymal Stromal Cells

Mesenchymal stromal cells (MSCs) are multipotent cells that can differentiate into various cell types, such as osteoblasts, myocytes, and adipocytes. This characteristic makes the cells a useful tool in developing new therapies for a number of common maladies and diseases. The utilization of animal-derived growth serum, such as fetal bovine serum (FBS), for the expansion of MSCs has traditionally been used for cell culture. However, in clinical applications, animal-derived products present limitations and safety concerns for the recipient, as exposure to animal (xeno-) antigens and infectious agents is possible. Multiple synthetic, xeno-free media have been developed to combat these limitations of animal-derived growth serum and have the potential to be used in ex vivo MSC expansion for clinical use. The goal of this study was to determine if xeno-free media are adequate to significantly and efficiently expand MSCs derived from adipose tissue. MSCs were cultured in both standard FBS-containing as well as xeno-free media. The media were compared for cell yield, viability, and phenotypic expression via flow cytometry and directed differentiation. The xeno-free media that were tested were StemMACS MSC Expansion Media (Miltenyi Biotec, Bergisch Gladbach, Germany), PLTMax Human Platelet Lysate (Sigma-Aldrich, St. Louis, MO, USA), and MesenCult-hPL media (Stemcell Technologies, Vancouver, BC, Canada). All xeno-free media showed promise as a feasible replacement for animal-derived growth serums. The xeno-free media expanded MSCs more quickly than the FBS-containing medium and also showed great similarity in cell viability and phenotypic expression. In fact, each xeno-free media produced a greater viable cell yield than the standard FBS-containing medium.

[1]  M. Potgieter,et al.  Making the Switch: Alternatives to Fetal Bovine Serum for Adipose-Derived Stromal Cell Expansion , 2016, Front. Cell Dev. Biol..

[2]  Z. Tan,et al.  Age-related BMAL1 change affects mouse bone marrow stromal cell proliferation and osteo-differentiation potential , 2012, Archives of medical science : AMS.

[3]  C. Jorgensen,et al.  Mesenchymal stem cells in osteoarticular pediatric diseases: an update , 2012, Pediatric Research.

[4]  R. Suuronen,et al.  The Potential of Adipose Stem Cells in Regenerative Medicine , 2011, Stem Cell Reviews and Reports.

[5]  R. Tuan,et al.  Regulation of stemness and stem cell niche of mesenchymal stem cells: Implications in tumorigenesis and metastasis , 2010, Journal of cellular physiology.

[6]  J. Goh,et al.  Multilineage potential of bone-marrow-derived mesenchymal stem cell cell sheets: implications for tissue engineering. , 2010, Tissue engineering. Part A.

[7]  M. Vemuri,et al.  Serum-free, xeno-free culture media maintain the proliferation rate and multipotentiality of adipose stem cells in vitro. , 2009, Cytotherapy.

[8]  M. Hedrick,et al.  Fat tissue: an underappreciated source of stem cells for biotechnology. , 2006, Trends in biotechnology.

[9]  V. Zachar,et al.  Enabling Technologies for Cell-Based Clinical Translation Comparative Analysis of Media and Supplements on Initiation and Expansion of Adipose-Derived Stem Cells , 2016 .

[10]  W. Liu,et al.  BMC Cell Biology BioMed Central , 2007 .